Protective immune responses in ducklings induced by a suicidal DNA vaccine of the VP1 gene of duck hepatitis virus type 1

Veterinary Microbiology

Volumn 160, Issue 3-4, 2012, Pages 314-318

  Fu, Yuzhi ^a,b   Chen, Zongyan ^a   Li, Chuanfeng ^a   Liu, Guangqing ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b HUNAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

Duck hepatitis virus; Ducklings; Suicidal DNA vaccine; VP1 gene

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DNA VACCINE; NEUTRALIZING ANTIBODY; SUICIDAL DNA VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE; VIRUS VECTOR;

ARTICLE; DUCK; DUCK HEPATITIS VIRUS TYPE 1; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS VIRUS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOFLUORESCENCE; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOLECULAR CLONING; NONHUMAN; SEROLOGY; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE;

ANIMALS; ANTIBODIES; BIRD DISEASES; CELL LINE; DUCKS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS VIRUS, DUCK; PICORNAVIRIDAE INFECTIONS; PLASMIDS; SEMLIKI FOREST VIRUS; VACCINES, DNA; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES; VIREMIA; VIRUS REPLICATION;

DUCK HEPATITIS B VIRUS; RABBIT FIBROMA VIRUS; SEMLIKI FOREST VIRUS;

EID: 84869095242     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2012.06.022     Document Type: Article

References (24)

1. Alarcon J.B., Waine G.W., McManus D.P. DNA vaccines: technology and application as anti-parasite and anti-microbial agents. Adv. Parasitol. 1999, 42:343-410.
2. Berglund P., Smerdou C., Fleeton M.N., Tubulekas I., Liljeström P. Enhancing immune responses using suicidal DNA vaccines. Nat. Biotechnol. 1998, 16:562-565.
3. Crighton G.W., Woolcock P.R. Active immunisation of ducklings against duck virus hepatitis. Vet. Rec. 1978, 102:358-361.
4. Deshpande M.S., Ambagala T.C., Hegde N.R., Hariharan M.J., Navaratnam M., Srikumaran S. Induction of cytotoxic T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization. Vaccine 2002, 20:3744-3751.
5. Ding C., Zhang D. Molecular analysis of duck hepatitis virus type 1. Virology 2007, 361:9-17.
6. Gerdts V., Jöns A., Makoschey B., Visser N., Mettenleiter T.C. Protection of pigs against Aujeszky's disease by DNA vaccination. J. Gen. Virol. 1997, 78:2139-2146.
7. Haider S.A., Calnek B.W. In vitro isolation, propagation, and characterization of duck hepatitis virus type III. Avian Dis. 1979, 23:715-729.
8. Hariharan M.J., Driver D.A., Townsend K., Brumm D., Polo J.M., Belli B.A., Catton D.J., Hsu D., Mittelstaedt D. DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J. Virol. 1998, 72:950-958.
9. Kim M.C., Kwon Y.K., Joh S.J., Lindberg A.M., Kwon J.H., Kim J.H., Kim S.J. Molecular analysis of duck hepatitis virus type 1 reveals a novel lineage close to the genus Parechovirus in the family Picornaviridae. J. Gen. Virol. 2006, 87:3307-3316.
10. Kirman J.R., Turon T., Su H., Li A., Kraus C., Polo J.M., Belisle J., Morris S., Seder R.A. Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A. Infect. Immun. 2003, 71:575-579.
11. Leitner W.W., Hwang L.N., DeVeer M.J., Zhou A., Silverman R.H., Williams B.R., Dubensky T.W., Ying H., Restfo N.P. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat. Med. 2003, 9:33-39.
12. Leitner W.W., Ying H., Restifo N.P. DNA and RNA-based vaccines: principles, progress and prospects. Vaccine 1999, 18:765-777.
13. Leitner W.W., Ying H., Driver D.A., Dubensky T.W., Restifo N.P. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors. Cancer Res. 2000, 60:51-55.
14. Levine P.P., Fabricant J. A hitherto-undescribed virus disease of ducks in North America. Cornell Vet. 1950, 40:71-86.
15. Lundstrom K. Alphavirus vectors: applications for DNA vaccines production and gene expression. Intervirology 2000, 43:247-257.
16. McNulty M.S. Picornaviridae. Poultry Diseases 2001, 305-318. W.B. Saunders, London. fifth ed. F. Jordan, M. Pattison, D. Alexander, T. Faragher (Eds.).
17. Oka Y., Akbar S.M., Horiike N., Joko K., Onji M. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice. Immunology 2001, 103:90-97.
18. Sun S., Liu X., Guo H., Yin S., Shang Y., Feng X., Liu Z., Xie Q. Protevtive immune responses in guinea pigs and swine induced by a suicidal DNA vaccine of the capsid gene of swine vesicular disease virus. J. Gen. Virol. 2007, 88:842-848.
19. Tacket C.O., Roy M.J., Widera G., Swain W.F., Broome S., Edelman R., et al. Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine 1999, 17:2826-2829.
20. Toth T.E. Studies of an agent causing mortality among ducklings immune to duck virus hepatitis. Avian Dis. 1969, 13:834-846.
21. Tseng C.H., Knowles N.J., Tsai H.J. Molecular analysis of duck hepatitis virus type 1 indicates that it should be assigned to a new genus. Virus Res. 2006, 123:190-203.
22. Wildy P. Classification and nomenclature of viruses: first report of the International Committee on Taxonomy of Viruses. Monogr. Virol. 1971, 5:1-118.
23. Woolcock P.R., Crighton G.W. Duck virus hepatitis: the effect of attenuation on virus stability in duckling. Avian Pathol. 1981, 10:113-119.
24. Woolcock P.R. Duck hepatitis. Diseases of Poultry 2008, 343-354. Iowa State University Press, Ames. Y.M. Siaf (Ed.).